Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: David Howe who wrote (1066)	8/7/1998 12:10:00 AM
From: M. Ramle	Read Replies (3) \| Respond to of 10280

David: Very well said. I tip my hat to your easy and very realistic commentary. I am betting that my end of August, SEPR will be in the high 60's. GOOD LUCK. Mazen

To: David Howe who wrote (1066)	8/7/1998 2:07:00 PM
From: rkrw	Read Replies (1) \| Respond to of 10280

Dave, I am quite curious as to how you figure $5-$8 dollars in 2001 eps and further how that is conservative. If anyone else wants to chime in and answer for Dave, please do so. I am very interested to see just how wild and contagious optimism can get in the face of a soaring stock price.

To: David Howe who wrote (1066)	8/12/1998 10:04:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

David, Congrats on your call of $50 being a bargain! We are just talking semantics here but I still say that a company is in the development stage until it has reported its first quarter where cash inflow is at least enough to cover all expenses before R&D. SEPR has now blown right through the $2 billion market cap. figure (using 36 mm shares fully diluted). Wonder what the record market cap. is for a company that is still a minimum of 2 years away from generating its first penny of EPS. Well, lets keep the internet stocks out of this.... in fact lets keep this restricted to the biotech crowd. So maybe some of the historians in the peanut gallery can tell us....what was the market cap. of Amgen or Biogen or Genentech a couple of years before they started generating earnings?